Example of Characterization Data Available
Lot #
Example 1
Example 2
Example 3
Example 4
Example 5
Example 6
Example 7
Example 8
Example 9
Example 10
Age
66
39
38
66
48
30
48
44
36
27
Gender
Male
Male
Male
Male
Male
Male
Male
Male
Male
Male
Ethnicity
Caucasian
Caucasian
Caucasian
Caucasian
Indonesian
/Dutch
Hispanic
Caucasian
Caucasian
Caucasian
Caucasian
HLA Type**
A
A2
A2
A1
A2
A2
A2
A2
A11
A2
A24
A
A11
Ax
A2
Ax
A2
A2
A2
A11
A29
A29
B
B44
B49
B8
B7
B44
B44
B8
B<41
B8
B44
B
B60
B60
B60
B57
B61
B<49
B39
B65
B60
B45
Bw4
Bw4
Bw4
-
Bw4
-
Bw4
-
-
-
Bw4
Bw6
Bw6
Bw6
Bw6
Bw6
Bw6
-
Bw6
Bw6
Bw6
-
C
C3
C3
C2
C6
Cz
Cw5
C7
C7
C3
C5
C
C5
C8
C7
C7
Cz
Cz
Cz
Cz
C7
Cz
IFN-y ELISpot Assay
-
HLA
Restriction
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Ave SFC*
Medium
N/A
3.00
1.67
0.33
0.00
6.67
3.00
1.00
4.00
1.67
13.67
CEF pool
N/A
415.00
1088.33
185.33
299.00
903.67
404.00
514.33
55.00
518.00
12.67
Flu PB 591
A1
4.67
3.67
40.00
0.67
4.67
2.67
2.67
4.67
2.67
13.00
Flu NP 44
A1
1.67
0.67
12.00
2.00
4.33
4.00
1.67
8.00
1.33
3.33
EBV BMLF1 259
A2
14.33
12.33
0.00
7.33
44.67
65.00
13.67
0.67
6.00
6.00
Flu Mat1 58
A2
61.33
688.67
97.00
31.00
84.67
120.67
220.00
2.67
57.67
6.33
HCMV pp65 495
A2
85.67
990.00
1.33
34.67
257.67
2.67
282.67
1.33
2.33
47.33
Flu NP 265
A3
3.00
25.00
0.33
0.67
4.33
2.67
8.67
3.00
0.33
10.67
EBV BRLF1 148
A3
8.67
183.67
0.67
1.67
16.00
7.00
34.67
1.00
1.67
115.00
EBV EBNA3a 603
A3
9.67
333.33
0.00
3.67
29.00
4.33
91.67
0.33
0.33
17.00
EBV EBNA3b 416
A11
133.67
0.67
0.00
36.00
5.33
2.00
1.33
1.33
1.00
33.33
EBV BRLF1 134
A11
2.67
2.33
0.33
0.67
3.00
1.33
0.33
1.33
0.67
4.33
EBV BRLF1 28
A24
2.67
1.00
0.67
1.33
4.33
1.33
2.67
1.33
1.33
8.67
Flu NP 91
AA68
24.00
1.00
0.67
64.00
6.33
4.00
1.00
15.33
1.67
25.67
HCMV pp65 417
B0702
2.00
1.33
0.33
70.33
2.00
4.67
1.33
3.00
2.33
7.33
EBV EBNA3a 379
B7
20.00
665.67
0.33
137.00
69.67
2.00
167.33
1.67
19.67
6.00
EBV EBNA3a 158
B8
2.33
0.33
0.33
3.67
9.67
1.00
7.67
0.33
28.00
5.67
EBV EBNA3a 325
B8
4.33
0.33
23.33
1.00
4.00
2.00
25.33
2.00
279.67
11.33
EBV EBNA3a 190
B8
4.00
0.67
0.00
10.00
4.67
2.33
134.33
8.33
138.00
38.33
FLU NP 380
B8
3.67
0.33
35.33
0.67
3.67
1.00
23.67
2.33
18.00
5.33
EBV EBNA3c 258
B27
3.00
1.33
0.33
1.33
6.00
3.67
2.33
0.33
0.33
4.00
FLU NP 383
B27
29.00
718.67
0.33
17.67
86.00
2.67
207.00
1.33
2.33
3.67
EBV EBNA3a 458
B35
4.67
0.33
0.33
8.67
5.00
15.67
2.00
1.00
2.33
9.33
EBV EBNA3c 281
B44
2.33
1.33
0.33
28.67
4.67
219.33
0.67
1.00
0.67
5.67
HCMV pp65
B44
8.33
0.00
0.33
0.67
6.00
2.33
1.00
1.33
2.00
10.67
Candida
N/A
251.00
94.67
114.67
35.67
411.67
394.33
148.00
511.00
376.33
934.67
Mumps
N/A
223.33
28.33
46.33
42.67
761.00
136.33
53.33
183.00
43.33
225.33
Dust Mite Mix
N/A
27.67
21.50
17.33
33.00
144.00
140.33
80.67
387.00
174.00
647.67
PPD
N/A
50.00
21.00
76.33
64.33
491.00
135.33
106.33
254.00
93.33
757.67
Tetanus
N/A
33.00
15.67
43.67
77.33
158.33
207.33
81.33
155.33
121.33
729.00
PHA
N/A
967.67
830.67
811.00
954.67
TNTC
TNTC
TNTC
TNTC
869.67
TNTC
Intracellular
Cytokine Assay
% pos
% pos
% pos
% pos
% pos
% pos
% pos
% pos
% pos
% pos
IFN-y
34.0
29.7
20.6
30.0
18.0
29.6
32.3
18.6
29.0
22.5
IL-2
19.8
17.1
16.00
19.1
20.0
19.7
13.8
14.9
12.3
11.0
CD8
33.4
29.8
26.8
43.3
33.4
30.3
35.0
20.5
33.7
29.4
CD3
100.0
100.0
100.0
100.0
100.0
100.00
100.0
100.0
100.00
100.0
CD4
58.0
63.5
62.9
48.0
63.1
68.3
52.1
73.2
56.9
66.7
CD3+CD4+IFN-y+
15.5
15.7
11.6
10.9
9.4
13.6
11.4
9.9
10.9
12.0
CD3+CD4+IL2+
17.3
13.8
12.6
11.3
13.6
16.8
10.9
12.8
9.7
8.7
CD3+CD8+IFN-y+
15.7
11.6
7.4
15.2
7.4
15.8
15.2
6.9
15.6
9.6
CD3+CD8+IL2+
2.9
3.6
3.7
7.6
6.4
3.5
2.8
1.9
2.6
2.4